VisilizuMab, also known as Nuvion, is a monoclonal antibody developed by Protein Design Labs. It is designed to target and neutralize the activity of a specific protein involved in the immune response, making it a potential therapeutic agent for various conditions related to the immune system.
219716-33-3
Post Buying Request-
-
Basic information
- Product Name: VisilizuMab
- Synonyms: VisilizuMab
- CAS NO:219716-33-3
- Molecular Formula:
- Molecular Weight: 0
- EINECS: N/A
- Product Categories: N/A
-
Chemical Properties
- Melting Point: N/A
- Boiling Point: N/A
- Flash Point: N/A
- Appearance: /
- Density: N/A
- Refractive Index: N/A
- Storage Temp.: N/A
- Solubility: N/A
- CAS DataBase Reference: VisilizuMab(CAS DataBase Reference)
- NIST Chemistry Reference: VisilizuMab(219716-33-3)
- EPA Substance Registry System: VisilizuMab(219716-33-3)
-
Safety Data
- Hazard Codes: N/A
- Statements: N/A
- Safety Statements: N/A
- WGK Germany:
- RTECS:
- HazardClass: N/A
- PackingGroup: N/A
- Hazardous Substances Data: 219716-33-3(Hazardous Substances Data)
219716-33-3 Suppliers
Recommended suppliers
219716-33-3 Usage
Uses
Used in Pharmaceutical Industry:VisilizuMab is used as a therapeutic agent for the treatment of organ transplantation rejection and other T lymphocyte-mediated diseases and disorders, including autoimmune diseases. Its monoclonal antibody nature allows for targeted treatment, reducing the risk of side effects associated with non-specific immunosuppressive therapies.
Used in Organ Transplantation:
VisilizuMab is used as an immunosuppressive agent to prevent organ rejection in transplant recipients. By targeting specific immune cells, it helps to reduce the risk of graft rejection and improve the success rate of organ transplants.
Used in Autoimmune Diseases:
VisilizuMab is used as a treatment option for patients with various autoimmune diseases, where the immune system mistakenly attacks the body's own tissues. Its targeted approach can help to modulate the immune response and alleviate symptoms associated with these conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 219716-33-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,1,9,7,1 and 6 respectively; the second part has 2 digits, 3 and 3 respectively.Calculate Digit Verification of CAS Registry Number 219716-33:
(8*2)+(7*1)+(6*9)+(5*7)+(4*1)+(3*6)+(2*3)+(1*3)=143
143 % 10 = 3
So 219716-33-3 is a valid CAS Registry Number.
219716-33-3Upstream product
219716-33-3Downstream Products
Post a RFQ
1
What can I do for you?
Get Best Price
Get Best Price for 219716-33-3
VisilizuMab
